As a member of the S100 family, S100A2 is considered a candidate tumor-suppressor gene. Recently, p63 gene, a new member of the p53 gene family, has been studied in the fields of tumorigenesis, cell apoptosis and tissue growth. At present, few studies have been carried out on the expression and relationship of S100A2 and p63 [...]

The US Food and Drug Administration’s (FDA) approval of a new one-pill formulation of the emergency contraceptive Plan B® represents a positive step forward for women’s health, according to The American College of Obstetricians and Gynecologists (ACOG). The new formulation of emergency contraception (EC), called Plan B® One-Step, will simplify this important pregnancy prevention treatment.

The European Commission has published two guidelines concerning the application of Articles 8(1), (2) and (3) of Regulation (EC) No 141/2000 on orphan medicinal products.
These relate to:

Breast cancer is the most common type of cancer and second leading cause of cancer-related death in women, in the United States. However, little is known about breast cancer in women in their early 40s and younger. Ann Partridge, MD, MPH, who founded and directs the Program for Young Women with Breast Cancer at Dana-Farber [...]

Doctors have long encouraged patients with diabetes to exercise regularly to help control their insulin levels and to maintain a healthy weight. Now, breast oncologists at Dana-Farber Cancer Institute in Boston are studying the relationship between exercise, weight, and insulin levels and the risk of breast cancer recurrence.